Read + Share
Mashimo Y, Yamazaki K, Kageyama T, Tanaka S, et al. Germline variants of IGHV3-53 / V3-66 are determinants of antibody responses to
the BNT162b2 mRNA COVID-19 vaccine. J Infect 2022 Nov 2. pii: S0163-4453(22)00614.
PMID: 36341890
|
 |
|
Mashimo Y, Yamazaki K, Kageyama T, Tanaka S, et al. Germline variants of IGHV3-53 / V3-66 are determinants of antibody responses to
the BNT162b2 mRNA COVID-19 vaccine. J Infect 2022 Nov 2. pii: S0163-4453(22)00614.
PMID: 36341890
|
|
|
|